Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2025)

Historic Interest Income - Net for Abeona Therapeutics (ABEO) over the last 5 years, with Q3 2025 value amounting to $771000.0.

  • Abeona Therapeutics' Interest Income - Net rose 78620.69% to $771000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 4965.8%. This contributed to the annual value of $38000.0 for FY2024, which is 9776.34% down from last year.
  • Abeona Therapeutics' Interest Income - Net amounted to $771000.0 in Q3 2025, which was up 78620.69% from $70000.0 recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Interest Income - Net peaked at $771000.0 during Q3 2025, and registered a low of -$676000.0 during Q3 2021.
  • Its 5-year average for Interest Income - Net is $109882.4, with a median of $87000.0 in 2024.
  • In the last 5 years, Abeona Therapeutics' Interest Income - Net crashed by 14144.49% in 2024 and then soared by 78620.69% in 2025.
  • Abeona Therapeutics' Interest Income - Net (Quarter) stood at -$48000.0 in 2021, then surged by 412.5% to $150000.0 in 2022, then skyrocketed by 322.67% to $634000.0 in 2023, then crashed by 109.31% to -$59000.0 in 2024, then surged by 1406.78% to $771000.0 in 2025.
  • Its last three reported values are $771000.0 in Q3 2025, $70000.0 for Q2 2025, and $312000.0 during Q1 2025.